These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 12435086)
1. Effect of melatonin on hyperlipidemic nephropathy under constant light exposure. Túnez L; Muñoz MC; Feijoo-López AL; Valdvira E; Bujalance-Arenas L; Montilla P J Physiol Biochem; 2002 Jun; 58(2):109-14. PubMed ID: 12435086 [TBL] [Abstract][Full Text] [Related]
2. Hyperlipidemic nephropathy induced by adriamycin: effect of melatonin administration. Montilla P; Túnez I; Muñoz MC; López A; Soria JV Nephron; 1997; 76(3):345-50. PubMed ID: 9226237 [TBL] [Abstract][Full Text] [Related]
3. Protective role of melatonin and retinol palmitate in oxidative stress and hyperlipidemic nephropathy induced by adriamycin in rats. Montilla PL; Túnez IF; Muñoz de Agueda C; Gascón FL; Soria JV J Pineal Res; 1998 Sep; 25(2):86-93. PubMed ID: 9755029 [TBL] [Abstract][Full Text] [Related]
4. Melatonin effect on renal oxidative stress under constant light exposure. Túnez I; del Carmen Muñoz M; Feijoo M; Valdelvira ME; Rafael Muñoz-Castañeda J; Montilla P Cell Biochem Funct; 2003 Mar; 21(1):35-40. PubMed ID: 12579519 [TBL] [Abstract][Full Text] [Related]
5. Impact of light/dark cycle patterns on oxidative stress in an adriamycin-induced nephropathy model in rats. Escribano BM; Díaz-Moreno A; Tasset I; Túnez I PLoS One; 2014; 9(5):e97713. PubMed ID: 24852173 [TBL] [Abstract][Full Text] [Related]
6. Hyperlipidemic nephropathy induced by adriamycin in ovariectomized rats: role of free radicals and effect of 17-beta-estradiol administration. Montilla P; Túnez I; Muñoz MC; Delgado MJ; Salcedo M Nephron; 2000 May; 85(1):65-70. PubMed ID: 10773758 [TBL] [Abstract][Full Text] [Related]
7. The influence of lipoic acid on adriamycin-induced hyperlipidemic nephrotoxicity in rats. Malarkodi KP; Balachandar AV; Varlakshmi P Mol Cell Biochem; 2003 May; 247(1-2):139-45. PubMed ID: 12841641 [TBL] [Abstract][Full Text] [Related]
8. The influence of thymoquinone on doxorubicin-induced hyperlipidemic nephropathy in rats. Badary OA; Abdel-Naim AB; Abdel-Wahab MH; Hamada FM Toxicology; 2000 Mar; 143(3):219-26. PubMed ID: 10755708 [TBL] [Abstract][Full Text] [Related]
9. Modulating effect of atorvastatin on paraoxonase 1 activity in type 2 diabetic Egyptian patients with or without nephropathy. Abdin AA; Hassanien MA; Ibrahim EA; El-Noeman Sel-D J Diabetes Complications; 2010; 24(5):325-33. PubMed ID: 19553142 [TBL] [Abstract][Full Text] [Related]
10. Beneficial cardio-renovascular effects of a low-molecular-weight heparin-derivative on adriamycin-induced glycosaminoglycanuria and tissue lipid abnormalities. Deepa PR; Varalakshmi P Toxicology; 2005 Jul; 211(1-2):77-85. PubMed ID: 15863250 [TBL] [Abstract][Full Text] [Related]
11. Treatment with irbesatan may improve slit diaphragm alterations in rats with adriamycin-induced nephropathy. Wang N; Wei RB; Li P; Li QP; Yang X; Yang Y; Huang MJ; Wang R; Yin Z; Lv Y; Chen XM J Renin Angiotensin Aldosterone Syst; 2016; 17(2):1470320316646884. PubMed ID: 27169889 [TBL] [Abstract][Full Text] [Related]
12. Effect of ciprofibrate on lipoproteins, fibrinogen, renal function, and hepatic enzymes. Rizos E; Bairaktari E; Ganotakis E; Tsimihodimos V; Mikhailidis DP; Elisaf M J Cardiovasc Pharmacol Ther; 2002 Oct; 7(4):219-26. PubMed ID: 12490967 [TBL] [Abstract][Full Text] [Related]
18. On the rise in low density and high density lipoproteins in response to the treatment of hypertriglyceridaemias in type IV and type V hyperlipoproteinaemias. Carlson LA; Olsson G; Ballantyne D Atherosclerosis; 1977 Apr; 26(4):603-9. PubMed ID: 193526 [TBL] [Abstract][Full Text] [Related]
19. Hypolipidemic potential of perillaldehyde-loaded self-nanoemulsifying delivery system in high-fat diet induced hyperlipidemic mice: Formulation, in vitro and in vivo evaluation. Omari-Siaw E; Zhu Y; Wang H; Peng W; Firempong CK; Wang YW; Cao X; Deng W; Yu J; Xu X Eur J Pharm Sci; 2016 Mar; 85():112-22. PubMed ID: 26851382 [TBL] [Abstract][Full Text] [Related]
20. Combined hyperlipidemia and hypertriglyceridemia in renal allograft recipients. Comparison with non-renal combined hyperlipidemic or hypertriglyceridemic patients and normal subjects. Somer JB; Abbott LK; Aitken JM; Elliott C Clin Chim Acta; 1979 Oct; 97(2-3):123-34. PubMed ID: 226288 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]